Patient Recruitment Featured Articles

1. Racial Inequities In Medicine: The Consequences Of Historical Unethical Experimentation In Clinical Trials 4/22/2025

   In part two of this series on racial inequities in clinical research, the authors discuss the impact those trials have had on clinical research in the Black community, especially for women.

2. Racial Inequities In Medicine: The History Of Unethical Race-Based Experimentation 4/21/2025

   Unethical and even brutal clinical research of the 19th and 20th centuries targeted the Black community. Discover how the medical mistreatment of Black patients and participants shaped how the community sees trials today.

3. Japan's Adoption Of DCTs Is Slow But Steady 4/16/2025

   While global momentum for DCTs accelerates, Japanese healthcare institutions face unique structural and operational hurdles to implement remote and digital trial activities.

4. Gilead Prioritizes Women With Its First HIV Cure Trial In Africa 3/28/2025

   Gilead’s Head Of HIV Cure Program Strategy Devi SenGupta discusses the challenges and triumphs of a groundbreaking HIV cure trial in South Africa.

5. As FDA's "Sex Differences" Guidance Reemerges, UCB Reaffirms Importance Of Including Women In Clinical Research 3/26/2025

   UCB Biopharma's Marie Teil explores reasons to prioritize women's inclusion in research and how FDA guidance is poised to support that endeavor.

6. Gilead Sees Success With HIV PrEP Trial In South Africa 3/24/2025

   Gilead Sciences' Moupali Das, MD, MPH shares how her team completed the Phase 3 trial for HIV PrEP in South Africa amid challenging conditions.

7. HLA Typing For HSCT: New Research Indicates Expanded Patient Compatibility 3/20/2025

   A challenge in hematopoietic stem cell transplantation (HSCT) is finding a fully matched unrelated donor. Recent advances in research and human leukocyte antigen (HLA) typing are allowing more patients to be matched.

8. We Need More Black Patients In Multiple Myeloma Clinical Trials 3/17/2025

   Malignant hematologist Craig Cole, MD exposes the health disparity for Black people with multiple myeloma and encourages researchers, with specific tips on how to do so, to include more Black people in trials for MM therapies.

9. Takeda's Diversity Strategy Pays Off For Phase 3 Trial 3/12/2025

   LaShell Robinson, head of global feasibility and trial equity at Takeda explains how the company’s Phase 3 trial for a psoriasis drug ended enrollment well before it’s goal and achieved some impressive diversity metrics. 

10. Lessons Learned From Vivani Medical's Study Of GLP-1 Implant 3/5/2025

    Vivani Medical Cofounder and CEO Adam Mendelsohn, Ph.D. discusses the company’s first application of the NanoPortal, including its upsides for patient adherence, its optimized trial design,  and its reception among sites and patients.